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Early Osteogenic Differential Protein Profile Detected by Proteomic Analysis in 
Human Periodontal Ligament Cells   
 
Abstract  
Background and Objective: Human periodontal ligament cells (PDLCs) play a pivotal 
role in maintaining periodontal ligament space, have the ability to differentiate into 
cementoblasts/osteoblasts-like cells, and a tremendous potential to regenerate periodontal 
tissue. The exact molecular mechanisms governing the differentiation status of PDLCs 
remains largely unknown. This study was to investigate the differentially expressed 
proteins involved in the osteogenic differentiation of PDLCs.  
Material and Methods: Using two-dimensional gel electrophoresis (2D-DIGE), mass 
spectrometry (MS), and peptide mass fingerprinting (PMF), we have analyzed the 
differential protein profiles of PDLCs undergoing mineralization condition. 
Results: Compared to undifferentiated PDLCs, 61 proteins with at least a 1.5-fold change 
were detected, of which 29 differentially expressed proteins were successfully identified 
by matrix assisted laser desorption ionization time-of-flight mass spectrometry 
(MALDI-TOF MS). The expression of some of the identified proteins was further 
confirmed by western blot and RT-PCR analysis. The identified proteins were found to 
belong to cytoskeleton proteins and cytoskeleton-associated proteins, nuclear proteins 
and cell membrane-bound molecules. 
Conclusion: Our results suggest that these proteins may be associated with the unique 
function of PDLCs in maintaining periodontal tissue homeostasis, providing a 
comprehensive reference to understand and further study the molecular mechanisms of 
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PDLCs involved in periodontal regeneration.  
  
Keywords: Human periodontal ligament cells; Osteogenic differentiation; Proteomics; 
2D- DIGE.  
 
Introduction 
The periodontal ligament (PDL) is a narrow fibrous connective tissue that connects the 
alveolar bone to teeth and plays an important role in providing anchorage and supporting 
tooth function, maintaining homeostasis, and repairing damaged tissue in response to 
periodontal disease or mechanical trauma. PDL contains a heterogeneous cell population 
at various stages of differentiation and lineage commitment. Previous studies indicate that 
periodontal ligament cells (PDLCs) can form mineralized nodules in vitro and express 
bone-related proteins, such as alkaline phosphatase (ALP), bone sialoprotein (BSP) and 
osteocalcin (OCN) (1-3). Recently Seo et al. reported that PDLCs contain stem cells with 
high proliferative capacity, self-renewal propertie, multilineage differentiation potential, 
and capable of forming cementum/PDL-like tissue in vivo (4). Thus, PDLCs play pivotal 
role in maintaining periodontal ligament space with the ability to differentiate into 
cementoblasts/osteoblasts-like cells, and have tremendous potential to regenerate 
periodontal tissue. However, a comprehensive understanding of molecular mechanisms 
controlling PDLCs differentiation into functional cells remains poor. 
 
Proteomic techniques such as two-dimensional gel electrophoresis (2-DE), coupled with 
protein identification by mass spectrometry (MS) and bioinformatics, has led to a 
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revolution in the ability of researchers to tease out the temporal and spatial changes of the 
entire protein complement and their functions in a given cell type (5). The task of 
detecting changes in protein expression has recently been made possible by the 
introduction of difference in gel electrophoresis (DIGE) (6), This method increases 
statistical confidence when combining experimental repetition with internal standards and 
facilitates the identification of quantitative and qualitative protein alterations during cell 
differentiation. Proteomics techniques are now widely accepted as an important tool for 
finding potential biomarkers or studying the mechanisms of cell differentiation (7). In 
order to identify early differential proteins in PDLCs osteogenic differentiation, DIGE 
and MS based proteomics approaches were utilized to investigate PDLCs cultures for 7 
days in osteogenic culture conditions. Twenty-nine proteins were identified by matrix 
assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS), 
of which 12 were up-regulated and 17 were down-regulation during early osteogenic 
differentiation. 
Material and Methods 
PDLCs isolation and cell culture  
Healthy periodontal ligament tissues were collected from the middle third part of the root 
of premolars obtained from patients (12-18 years of age) undergoing orthodontic 
treatment in the Department of Orthodontics, Sun Yat-sen University Dental Hospital.  
Informed consent was obtained from each subject and the research protocols were 
approved by the University Ethic Committee. PDL tissues were minced and digested in a 
solution containing 3mg/mL type I collagenase (Worthington Biochem, Freehold, NJ, 
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USA) and 4mg/mL dispase (GIBCO-BRL Life Technologies, Breda, Netherlands) at 
370C for 30 to 60 minutes as previously described (4). The digested solution was filtered 
through a 70-μm strainer (Becton Dickinson, Sunnyvale, CA, USA) and the released cells 
plated in 6-well plates containing alpha modified Eagle’s medium (α-MEM, 
GIBCO-BRL) supplemented with 20% fetal bovine serum (FBS, GIBCO-BRL), 100 
units/mL penicillin and 100µg/mL streptomycin (Sigma, St. Louis, MO, USA), and 
incubated at 370C in 5% CO2. Cells from passages 2 to 4 were used in the following 
experiments.  
 
PDLCs surface characterization using flow cytometry analysis    
1×105  PDLCs at passage 2 were harvested in phosphate buffered solution (PBS) 
containing 1mM EDTA, washed in PBS, and then incubated with 0.5µg/100µL of mouse 
antihuman STRO-1 antibodies (R&D systems, Minneapolis, MN, USA) and CD146 
(Santa Cruz Biotechnology, Santa Cruz, CA) for 30 minutes at 4°C. Cells were washed 
twice with cold PBS containing 2% FBS and incubated with 1µg/100µL of fluorescein 
isothiocyanate (FITC onjugated goat antimouse IgM or IgG antibodies (Santa Cruz) for 
30 minutes at 4°C. Mouse antihuman antibodies to CD29-FITC, CD44-FITC, CD106-PE, 
CD34-FITC (BD Bioscience, Farmington, CT) were also used for phenotype 
characterization. Mouse isotype antibodies (BD Bioscience) served as a control. Labeled 
cells were analyzed by flow cytometer (Becton -Dickinson, Franklin Lakes, NJ, USA).  
The experiments were repeated three times on all three patient samples.  
 
Immunocytochemical staining and alizarin red staining 
Comment [QSOE1]: 0.5ug 
per mL?? 
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Cells at passage two were subcultured into 22×22mm slides (2×104cells/mL) for 24 hours 
and fixed in 4% paraformaldehyde for 15 minutes, then blocked and incubated with 
monoclonal antibody of anti-vimentin or anti-pancytokeratin (Boster Biotechnology, INC, 
Wuhan, China) at 1:100 dilution, and rabbit anti-mouse antibody was as a secondary 
antibody. 
Osteogenic differentiation of PDLCs was verified by the bone nodule formation after 
PDLCs had been cultured for 21 days in osteogenic media (α-MEM supplemented with 
10mM β-glycerophosphate, 0.2mM ascorbic acid, 100nM dexamethasone [Sigma] with 
15% FBS); controls were cultured in α-MEM with 15% FBS, Mineral deposits were 
detected at day 21 by 2% alizarin red staining, and osteocalcin expression was monitored 
at days 21 by immunocytochemical staining using polyclonal mouse antihuman 
osteocalcin (Santa Cruz Biotechnology, Santa Cruz, CA, USA, 1:100 dilution).  
 
Protein preparation 
PDLCs were cultured in osteogenic and control medium for 7 days. Prior to the harvest 
both the differentiated cells and controls were incubated with serum-free medium for 24 
hours after which the medium was removed and the cells washed three times with 
ice-cold Tris-buffered sucrose (10mM Tris-base, 250mM sucrose, pH 7.4). The cells were 
lysed with sodium dodecyl sulfate (SDS) lysis buffer containing 7M urea, 2M thiourea, 
4% CHAPS, and 30mM Tris (GE healthcare), the lysates sonicated on ice and then 
centrifuged at 20000g for 30 minutes at 40C. The protein samples were purified using the 
2-D Clean-Up Kit (GE healthcare) and protein content determined by 2D-Quant kit (GE 
healthcare) according to the manufacturer’s instructions. 
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CyDye labeling of extracted proteins and two-dimensional electrophoresis (2-DE) 
Prior to 2-DE the protein extracts were labeled with fluorescent cyanine dyes developed 
for 2-D DIGE technology (GE Healthcare) following the manufacturer’s 
recommendations. 50mg of differentiated and control proteins were labeled with Cy3 or 
Cy5, and 50mg of the internal standard mixture was labeled with Cy2 (Table 1), followed 
by incubation on ice for 30 minutes in the dark. The reactions were quenched by the 
addition of 1μL of 10mM lysine for 10 minutes on ice in the dark. The quenched Cy3- 
and Cy5-labeled samples and the Cy2-labeled internal standard were pooled prior to 
analysis by 2-DE. Two preparative gels, each containing 500mg of unlabeled mixture 
proteins, were analyzed, and four DIGE gels were run to analyze differentiated and 
control samples. 
2-DE was performed according to the manufacturer’s instructions (GE Healthcare). 
Briefly, immobilized dry strips (pH4-7, 24 cm, GE Healthcare) were rehydrated for 12 h 
in the 450μL rehydration buffer (7M urea, 2M thiourea, 4% w/v CHAPS, 1% v/v IPG 
buffer (pH 4–7) ,40mM DTT and 0.002% (w/v) Bromophenol blue ) at 30 V for 12 hours 
using an Ettan IPGphor II IEF system (GE Healthcare). After rehydration the samples 
were focused at 500 V for 1 hour, 1000 V for 1 hour, and at 8000 V for a total of 80000 
Vh at 200C. The strips were incubated in Equilibration Buffer I containing 6 M urea, 30% 
glycerol, 2% SDS, 50 mM Tris-HCl (pH 8.8), 1% DTT for 15 minutes at room 
temperature in the dark and then soaked in Equilibration Buffer II for an additional 15 
minutes.  Buffer II was identical to Buffer I with the exception of 2.5% iodoacetamide 
instead of 40mM DTT. The equilibrated strips were embedded in 0.5 w/v agarose on top 
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of 12.5% acrylamide slab gels. Second dimension separations were performed on an 
Ettan DALT six electrophoresis system (GE Healthcare). The proteins were separated 
initially at 150C, 2 W/gel for 50 minutes, followed by 17 W/gel until the dye front 
reached the bottom of the gel. The two preparative gels were stained with Deep purple 
total protein stain (RPN6306, GE Healthcare) following the manufacturer’s instructions.  
 
Gel scanning and image analysis 
Both sample and preparative gels were imaged using a Typhoon Variable Mode Imager 
9400 (GE Healthcare) using the excitation filters Blue 488nm (Cy2), Green 532nm (Cy3), 
Red 633nm (Cy5), and 532nm (Deep Purple) with the resolution of 100μm.  The 2-D 
image of the gel from each treated sample was compared to that of the control sample via 
the internal standard sample. Protein expression analysis was performed for each of the 
four gels in parallel using the differential in-gel analysis (DIA) module of DeCyder 
software 6.0 (GE Healthcare) using a value of 3000 as the initial estimation of the 
number of protein spots present. The intensities of individual protein spots of the 
proteomes of the differentiated samples were compared with the control. The DIA 
analysis data was collated into a single analysis using the DeCyder biological variation 
analysis (BVA) module, and final values for the expression ratio of specific protein spots 
between differentiated samples and the control were determined.  A total of 2787~3039 
protein spots were analyzed across all cell samples and Student’s t-test and one-way 
ANOVA were used to calculate significant differences in the relative abundance of 
individual protein spot features between differentiated samples and the control. Protein 
spots an abundance ratio greater than +1.5 or less than -1.5 were determined to be 
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differentially expressed. 
 
In-gel digestion and MALDI-TOF MS 
Selecting protein spots from the gels, in-gel digestion, peptides extraction, preparation of 
the samples for MS and spotting on target slides were carried out automatically with an 
Ettan spot handling workstation (GE Healthcare). Identification of proteins by peptide 
mass fingerprinting (PMF) was carried out on an Ettan MALDI-TOF mass spectrometer 
(GE Healthcare) operating in reflectron mode. Internal calibration was performed using 
the trypsin autodigestion peaks at m/z 842.509 and 2211.104. Mass spectra were obtained 
over the m/z range of 700–3000 Da. PMF data was used to search the human NCBI nr 
protein database using the Profound search engine (http://www. 
matrixscience.com/cgi/search_form.pl?FORMVER=2&SEARCH=PMF, GE Healthcare). 
Search parameters were as follows: type of search, peptide mass fingerprint; enzyme, 
trypsin; fixed modification, carbamidomethylation (Cys); variable modifications, 
oxidation (Met); mass values, monoisotopic; peptide charge state, 1+; maximum missed 
cleavages, 1; and peptide mass tolerance, 100ppm.  
 
Western blot  
PDLCs on days 0 (at 80% confluence, before the addition of osteogenic induction 
medium) and 7 of osteogenic induction were harvested and lysed in SDS lysis buffer, 
sonicated, and centrifuged at 12000g for 5 minutes. Equal amounts of protein (50μg) 
were separated by electrophoresis on a 12.5% polyacrylamide gel and transferred to 
nitrocellulose membranes by 100mA for 3 hours. The membranes were blocked in 5% 
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nonfat dry milk at room temperature for 1 hour, rinsed, and incubated with primary 
antibodies (1:1000 dilution) of mouse anti-human heteronuclear ribonuclear proteins 
C1/C2 (hnRNPC, Santa Cruz), mouse anti-human caldesmon (CaD), mouse anti-human 
tropomyosin (Tm), rabbit anti-human polyclonal antibody AnnexinA4 (Cell Signaling, 
LAB VISION Corporation NeoMarkers), or mouse anti-human β-actin (Santa Cruz) at 
40C overnight. The membranes were washed, then incubated with HRP-conjugated 
secondary antibodies (Santa Cruz, 1:5000 dilutions) at room temperature for 1 hour, and 
the proteins visualized using enhanced chemiluminescence (Amersham Pharmacia 
Biotech, Piscataway, NJ, USA). 
 
Quantitative real-time reverse-transcription polymerase chain reaction 
Prior to osteogenic induction and after 7 days of induction, cells were lysed to extract 
total RNA by using RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany). The primers 
used for detection were listed in Table 2. Quantifications of mRNAs were performed with 
an ABI Prism 7000 sequence detection system (Applied Biosystems, Foster City, CA). 
cDNA was synthesized from 1g of each RNA sample using the omniscript RT kit 
(Qiagen) and RNase-free DNase Set (Qiagen) following the manufacturer’s instructions, 
5µL of the reaction mixture was incubated with PCR master mix with double-stranded 
DNA dye SYBR Green I (Qiagen) in a total volume of 50µL. All reactions were run with 
a hot start preincubation step of 3 minutes at 93°C, followed by 40 cycles of 1 minute at 
93°C, 1 minute at 55°C, and 1 minute at 72°C. The amount of template was quantified by 
using the comparative cycle threshold method according to the manufacturer’s protocol.  
Measured mRNA levels were normalized against β-actin mRNA expression. Experiments 
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were performed in triplicates on three different cell samples.  
 
Statistical analysis 
All experiments have been repeated three to four times, and the representative results are 
presented. The quantitative data is presented as mean ± standard deviation. One-way 
analysis of variance (ANOVA) and Bonferroni test was performed to analyze mRNA 
expressions between induced samples and controls. Differences were considered 
significant at p<0.05. The SPSS software package (version 13.0, SPSS Inc., Chicago, IL, 
USA) was used for the statistical analysis. 
 
Results 
Cell characterization 
PDLCs expressed cell surface epitopes associated with mesenchymal progenitors such as 
STRO-1, CD-146, CD29, CD44, CD106, but did not express CD34, a hematopoietic 
origin marker as shown by flow cytometry. The expression of STRO-1, CD-146, CD29, 
CD44, CD106 was 15.3%, 47.6%, 99.9%, 99.8% and 76.8% respectively (Fig. 1A-F, 
Table 3). The positive immunocytochemical staining for vimentin antibody, the most 
widely distributed intermediate filament in fibroblasts, and negative staining for 
pancytokeratin, a marker for tissue of epithelial origin, indicated that the PDLCs islolated 
from PDL tissue in this study were of mesenchymal origin (Fig. 2A-B). 
Alizarin red positive nodules were seen in PDLC cultures on day 21 of osteogenic 
induction, however, no staining was detected in the controls (Fig. 2C). Furthermore, 
PDLCs showed positive expression of OCN after 21 days of osteogenic induction (Fig. 
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2D). Quantitative real-time RT-PCR showed an upregulation of ALP, OCN and matrix 
extracellular phosphoglycoprotein (MEPE) mRNA expressions in osteogenic culture 
conditions (Fig 3). The difference between the induced cells versus controls at the same 
time points was statistically significant (on days 14 and 21 for ALP and OCN, on day 21 
for MEPE, ANOVA, p﹤0.05 or p﹤0.001) for each transcript. These results suggest that 
PDLCs are able to differentiate into cementoblasts/osteoblasts in vitro. 
 
Osteogenic differential protein expression in PDLCs identified by 2D-DIGE and 
MALDI-TOF MS 
Protein profiles were compared between the osteogenic induced cells and controls. The 
DeCyder software detected more than 2,787 protein spots across all four gels. 61 protein 
spots showed at least 1.5-fold changes in expression of which 14 proteins were 
up-regulated and 47 proteins were down-regulated (p<0.05). The protein profile of 
2D-DIGE is shown in Figure 4. MALDI-TOF MS identified 29 proteins in PDLCs by 
their PMF using the Swiss-Prot database. These proteins were classified into seven 
functional categories: cytoskeleton proteins, nuclear proteins, cell membrane-bound 
molecules, proteins involved in matrix synthesis, protein synthesis, metabolic enzymes 
and signal transduction (Table 4). 
 
Western blot and RT-PCR analysis of up- or down-regulated proteins 
To confirm the results obtained in 2D-DIGE gels, several proteins, such as the 
cytoskeleton associated proteins caldesmon (CaD) and tropomyosin (Tm), heterogeneous 
nuclear ribonucleoprotein C (hnRNPC) and calcium-binding protein annexin A4, were 
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selected for the further confirmation by western blot and quantitative PCR (qPCR). The 
proteins and mRNA were extracted from PDLCs at days 0 and 7 of induction. Western 
blot analysis confirmed the down-regulation of CaD, Tm, hnRNPC and up-regulation of 
annexinA4 after osteogenic induction of PDLCs on days 7. Furthermore, qPCR analysis 
showed similar changes in mRNA expressions of CaD, Tm, hnRNPC and annexin A4 in 
osteogenic culture (Fig. 6). 
 
Discussion 
In this study, PDLCs isolated from periodontal ligament showed a similar profile of cell 
surface epitopes compared with the studies reported by others (4, 8, 9). Seo et al. showed 
that periodontal ligament stem cells (PDLSCs) are immunocytochemically positive for 
STRO-1 and CD146, markers which have been used to isolate and purify human bone 
marrow mesenchymal stem cells (MSCs) (4). By flow cytometry analysis, we found that 
the percentage of STRO-1 positive cells at passage 2 was higher than previously reported 
(8). Our findings that PDLCs expressed the mesenchymal stem cell-associated antigens 
CD44 and CD106 and an absence of hematopoietic marker CD34 expression agreed with 
that reported by Gronthos et al (9). These results indicate that PDLCs contain a 
population of mesenchymal stem cell. We also demonstrated that PDLCs formed a 
mineralized matrix and expressed the bone-related markers ALP, OCN and MEPE when 
grown in osteogenic media. These data suggest that cultured PDLCs may represent a 
heterogeneous stem-cell enriched population and have the potential to differentiate into 
cementoblasts or osteoblasts in vitro.  
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Although some growth factors, genes and signaling molecular have been identified in the 
process of cementogenesis/osteogenesis with conventional molecular biological 
approaches (10-12), the differentiation mechanisms of stem/progenitor cells in 
periodontal regeneration need to be further understood. Proteomic profiling analysis 
provides a complementary and potentially more comprehensive approach to tease out 
important protein candidates in the process of differentiation. In this study, PDLCs were 
induced along cementoblasts/osteoblasts lineages. Changes in protein expression levels 
during PDLCs differentiation on day 7 was determined by proteomics based on the 
highly sensitive 2D-DIGE and MALDI-TOF MS technologies. 29 differentially 
expressed proteins were identified in PDLCs during the cementoblast/osteoblast 
differentiation. These proteins mainly effect the cytoskeleton, nuclear regulation, cell 
membrane-bounding, matrix synthesis, metabolic enzymes and signal transduction.  
 
We found that cytoskeleton proteins, including vimentin, CaD, Tm and Clathrin heavy 
chain polypeptide (CHC), were down-regulated during cementoblastic/osteoblastic 
differentiation of PDLCs. Significant down-regulation of vimentin has been demonstrated 
in vitro in MSCs differentiating into cardiomyocytes (13), suggesting differentiation 
stage-specific reorganization of the cytoskeleton. In addition, vimentin exhibits a 
complex pattern of developmental and tissue-specific expression regulated by 
transforming growth factor beta 1 (TGFβ-1), which plays an important role in cell 
differentiation (14). CaD contains actin-, myosin-, tropomyosin-, and Ca2+-calmodulin 
(CaM)-binding domains (15), and is often regarded as differentiation marker of smooth 
muscle cells (16). CaD was down-regulated in MSCs during the process of neuron-like 
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differentiation (17), providing further evidence of its involvement in cell differentiation.  
CaD can be phosphorylated by p21-activated kinases (PAKs), a dynamic process required 
to regulate actin dynamics and membrane protrusions in wound-induced cell migration 
(18). As a natural partner of CaD, tropomyosin regulate actomyosin-based contractility, 
mediate the inhibitory effects of CaD on actomyosin and regulate cytokinesis speed and 
membrane stability during cell division (19). CHC, another actin filament binding protein 
identified in this study, has, together with Tm and annexin 4, been indentified to be 
involved in the osteogenic differentiation of MSCs (20).  An earlier proteomics study of 
periodontal ligament fibroblasts found that the expression of actin, vimentin and Tms 
were related to mechanical loading and remodeling of PDL (21). In our study, we found a 
down-regulation of vimentin, CaD, beta Tm, skeletal muscle Tm, CHC and related kinase 
PAK65 at day 7 of PDLCs osteogenic differentiation. Co-regulation of the functional 
class of proteins during PDLCs differentiation suggests that these cytoskeleton proteins 
are intimately involved in the differentiation process and that their regulation proceeds 
via similar regulatory mechanisms. It is possible that these proteins may be involved in 
regulating cell migration during the osteogenic differentiation of PDLCs, but this 
hypothesis needs to be confirmed by further experiments. 
 
The hnRNPC proteins (C1 and C2) belong to a class of proteins that bind to pre-mRNA 
in the cell nucleus. Increased expression of hnRNPC induced the translation of p27 
mRNA and triggered the inhibition of cell growth via p27 regulated cell cycle arrest (22).  
Forster and colleagues, applying a proteomic approach, observed the co-regulation of five 
members of hnRNPs family (hnRNP C1/C2, Q, U, K and G) during MSC osteogenic 
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differentiation; altered expression of hnRNPs was regarded to be related with cell 
adhesion (20). The down-regulation of hnRNP C1/C2 found in our study further supports 
this protein’s critical role in cell adhesion in PDLC osteogenic differentiation. In addition 
to hnRNP C1/C2 proteins, the two nuclear proteins nucleophosmin 1 (NPM1) and lamins 
A/C, were also down-regulated during PDLCs differentiation. NPM1 protein serves as a 
shuttle protein for the nuclear transport of ribosomal components and presumably 
collaborates with other nucleolar proteins in ribosome assembly (23). Nuclear lamins A/C 
are intermediate filament proteins which form the nuclear lamina underlying the inner 
nuclear membrane (24). The absence of lamin A/C has been identified as a novel marker 
for undifferentiated embryoic stem (ES) cells and lamin A/C expression as an early 
indicator of ES cell differentiation, indicating the functional role of lamin A/C in the 
maintenance of the differentiated state (25). The concomitant down-regulation of hnRNP 
C1/C2, NPM1 and lamin A/C in our study suggest that these nuclear proteins may work 
together to allow osteogenic differentiation of PDLCs to be proceed. 
 
Annexins belong to a family of structurally related of calcium-binding proteins (26), 
several of which have already been found to play roles in osteogenesis and mineralization.  
Ye et al found, by 2-DE and MS, that three isoforms of annexin A1 are down-regulated to 
various degrees during rat MSC differentiation (13). Other proteomics studies have 
demonstrated the differential expression of anexins A1, A2, A4 and V in hMSC 
osteogenic differentiation (27, 28). Annexin A4 is reported to regulate a 
calmodulin-dependent kinase II-activated (Ca2+/CaMKII) chloride conductance, and has 
been proposed to play a role in exocytosis, vesicle aggregation and trafficking in a 
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Ca2+-dependent manner (29-31). In our study both the protein and mRNA expression of 
annexins A4 were up-regulated in the mineralization process of PDLCs. Although some 
possible biological functions of annexin A4 have been proposed, the exact role of this 
molecule in osteogenic differentiation of PDLCs requires further investigation. 
It is worth noting that typical bone-related markers, such as ALP, OCN and MEPE, were 
not seen to be up-regulated in the proteomic map during early differentiation, although 
these markers were significantly up-regulated during the late stages of osteogenic 
differentiation of PDLCs, confirmed by qPCR. ALP is reported to be detectable in early 
osteogenic differentiation, but in our study neither mRNA nor protein levels showed any 
significant difference at day 7 of differentiation. One possible reason for this apparent 
variation may be the source of cells and differentiation protocols utilized in the various 
research laboratories. However, the early regulatory proteins identified in our study may 
provide some insights into the potential molecular interactions between early and late 
stage differential proteins.   
 
Conclusion 
In this study we present for the first time the differential protein expression profiles of 
PDLCs at day 7 of osteogenic induction. 29 proteins were identified by MS analysis 
showing differential expression during osteogenesis. These proteins mainly included 
cytoskeleton proteins and cytoskeleton-associated proteins, nuclear proteins, cell 
membrane-bound molecules, and may be associated with the unique function of PDLCs 
in maintaining periodontal tissue homeostasis, especially in the mineralization nature of 
PDL. Our results provide a comprehensive reference to understand and further study 
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molecular mechanisms of PDLCs in periodontal regeneration.  
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